Published in Glob Health Action on January 15, 2014
Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) (ADEPTT) | NCT03302299
How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa. Glob Health Action (2014) 1.00
A comparative analysis of national HIV policies in six African countries with generalized epidemics. Bull World Health Organ (2015) 0.93
Measuring HIV-related mortality in the first decade of anti-retroviral therapy in sub-Saharan Africa. Glob Health Action (2014) 0.83
Factors associated with mortality in HIV-infected people in rural and urban South Africa. Glob Health Action (2014) 0.79
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet (2008) 5.93
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr (2007) 3.38
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS (2006) 3.23
Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr (2004) 3.19
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol (2011) 2.80
Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda. Trop Med Int Health (2009) 2.33
Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS (2000) 2.15
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis (2009) 1.64
AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire. Clin Infect Dis (2012) 1.64
An HIV-1 natural history cohort and survival times in rural Uganda. AIDS (1997) 1.56
HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort. AIDS (1994) 1.53
Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther (2012) 1.50
The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. Int J Epidemiol (2013) 1.48
HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda. AIDS (2007) 1.41
Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr (2012) 1.18
Immunodeficiency and the risk of death in HIV infection. JAMA (1992) 1.17
Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa. J Acquir Immune Defic Syndr (2007) 1.17
Rationing antiretroviral therapy in Africa--treating too few, too late. N Engl J Med (2009) 1.02
Generalizability of population-based studies on AIDS: a comparison of newly and continuously surveyed villages in rural southwest Uganda. Int J Epidemiol (2002) 0.96
HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005. Int J Infect Dis (2007) 0.94
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa. J Acquir Immune Defic Syndr (2012) 0.89
Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men. AIDS (2000) 0.87